Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 954-957

  Vogel, Ulrich ^a   Claus, Heike ^a   Heinze, Gabriele ^a   Frosch, Matthias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATION; COLONY FORMING UNIT; GENETIC ANALYSIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 0032957239     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.954-957.1999     Document Type: Article

References (31)

1. Achtman, M. 1995. Global epidemiology of meningococcal disease, p. 159-175. In K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons, Ltd., Chichester, England.
2. Cartwright, K. 1995. Meningococcal carriage and disease, p. 115-146. In K. Cartwright (ed.), Meningococcal disease. John Wiley and Sons, Ltd., Chichester, England.
3. Claus, H., U. Vogel, M. Mühlenhoff, R. Gerardy-Schahn, and M. Frosch. 1997. Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules. Mol. Gen. Genet. 257: 28-34.
4. de la Paz, H., S. J. Cooke, and J. E. Heckels. 1995. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. Microbiology 141:913-920.
5. Dunn, K. L., M. Virji, and E. R. Moxon. 1995. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb. Pathog. 18:81-96.
6. Elkins, C., N. H. Carbonetti, V. A. Varela, D. Stirewalt, D. G. Klapper, and P. F. Sparling. 1992. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolvsaccharide is not sialylated. Mol. Microbiol. 6:2617-2628.
7. Estabrook, M. M., J. M. Griffiss, and G. A. Jarvis. 1997. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65:4436-4444.
8. Frangipane, J. V., and R. F. Rest. 1993. Anaerobic growth and cytidine 5′-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae. Infect. Immun. 61:1657-1666.
9. Frosch, M., C. Weisgerber, and T. F. Meyer. 1989. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningilidis group B. Proc. Natl. Acad. Sci. USA 86:1669-1673.
10. Gilbert, M., D. C. Watson, A. M. Cunningham, M. P. Jennings, N. M. Young, and W. W. Wakarchuk. 1996. Cloning of the lipooligosaccharide alpha-2,3-sialyltraasferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae. J. Biol. Chem. 271:28271-28276.
11. Hammerschmidt, S., C. Birkholz, U. Zähringer, B. D. Robertson, J. van Putten, O. Ebeling, and M. Frosch. 1994. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol. Microbiol. 11:885-896.
12. Jarvis, G. A. 1994. Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae. Infect. Immun. 62:1755-1760.
13. Jarvis, G. A., and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55:174-180.
14. Jennings, M. P., P. van der Ley, K. E. Wilks, D. J. Maskell, J. T. Poolman, and E. R. Moxon. 1993. Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis. Mol. Microbiol. 10:361-369.
15. Lee, F. K. N., D. S. Stephens, B. W. Gibson, J. J. Engstrom, D. Zhou, and M. A. Apicella. 1995. Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. Infect. Immun. 63:2508-2515.
16. Mandrell, R. E., and M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187:382-402.
17. Mandrell, R. E., J. J. Kim, C. M. John, B. W. Gibson, J. V. Sugai, M. A. Apicella, J. M. Griffiss, and R. Yamasaki. 1991. Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173:2823-2832.
18. Mandrell, R. E., J. M. Griffiss, and B. A. Macher. 1988. Lipooligosaccharides (LOS) of Neisseria gonorrhaeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize cross reacting antigens on LOS and human erythrocytes. J. Exp. Med. 168:107-126.
19. Massen, L., B. E. Holbein, and F. E. Ashton. 1982. Virulence linked to polysaccharide production in scrogroup B Neisseria meningitidis. FEMS Microbiol. Lett. 13:187-190.
20. Masson, L., and B. E. Holbein. 1985. Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis cupsular polysaccharide levels: correlation with virulence for mice. Infect. Immun. 47:465-471.
21. Moran, E. E., B. L. Brandt, and W. D. Zollinger. 1994. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect. Immun. 62:5290-5295.
22. r factor from human red blood cells which induces gonococcal resistance to killing by human serum. J. Gen. Microbiol. 134: 3295-3306.
23. Parsons, N. J., J. R. Andrade, P. V. Patel, J. A. Cole, and H. Smith. 1989. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-monophospho-N-acetyl neuraminic acid. Microb. Pathog. 7:63-72.
24. Ram, S., A. K. Sharma, S. D. Simpson, S. Gulati, D. P. McQuillen, M. K. Pangburn, and P. A. Rice. 1998. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187:743-752.
25. Robertson, B. D., M. Frosch, and J. P. van Putten. 1993. The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol. Microhiol. 8:891-901.
26. Ross, S. C., and P. Densen. 1984. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 63:243-273.
27. Vogel, U., H. Claus, G. Heinze, and M. Frosch. 1997. Functional characterization of an isogenic meningococcal α-2,3-sialyltransferase mutant: the role of lipooligosaccharide for serum resistance in serogroup B meningococci. Med. Microbiol. Immunol. (Berlin) 186:159-166.
28. Vogel, U., S. Hammerschmidt, and M. Frosch. 1996. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol. Immunol. (Berlin) 185:81-87.
29. Vogel, U., G. Morelli, K. Zurth, H. Claus, E. Kriener, M. Achtman, and M. Frosch. 1998. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J. Clin. Microbiol. 36:2465-2470.
30. Vogel, U., A. Weinberger, R. Frank, A. Müller, J. Köhl, J. P. Atkinson, and M. Frosch. 1997. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect. Immun. 65:4022-4029.
31. Wetzler, L. M., K. Barry, M. S. Blake, and E. C. Gotschlich. 1992. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect. Immun. 60:39-43.